Antibody targeted liposomal systems
Despite success in the development of clinically useful liposomal anticancer drugs, the advancement of targeted formulations has been limited to only a handful of successful studies in animal models of cancer. This thesis suggests that a fundamental lack of understanding of the biological fate of...
Main Author: | |
---|---|
Format: | Others |
Language: | English |
Published: |
2009
|
Online Access: | http://hdl.handle.net/2429/6702 |